OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31

Oscar Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$32.54+0.65 (+2.04%)

Close on Oct 19, 2026

Market cap: $10.85B
P/E (TTM): 23.2
Dividend yield: –

Oscar Health, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	11,701	9,178	5,863	3,964	1,839	463	488
Selling, General & Admin	2,050	1,756	1,426	1,257	–	–	–
General & Administrative	29	32	31	15	265	167	111
Total Costs & Expenses	12,098	9,120	6,098	4,554	2,383	865	748
Operating Income	-396	57	-236	-590	-544	-402	-259
Interest Expense	18	24	25	23	4.72	3.51	0
Other Non-Operating Income	-23	-0.11	-7.08	2.42	-1.20	–	–
Gain (Loss) on Investments	1.34	0.02	-0.07	-1.27	0.21	1.24	0.48
Pretax Income	-437	33	-267	-610	-571	-406	-259
Income Tax Expense	5.61	7.31	3.29	-0.52	0.85	1.05	1.79
Net Income incl. Noncontrolling Interests	-443	26	-271	-610	-571	-407	-261
Minority Interest in Earnings	0.25	0.69	0.13	-3.28	1.18	0	0
Net Income	-443	25	-271	-606	-573	-407	-261
Net Income to Common	-443	25	-271	-606	-573	-414	-261
EPS (Basic)(per share)	-1.69	0.11	-1.22	-2.85	-3.20	-14.16	-9.06
EPS (Diluted)(per share)	-1.69	0.10	-1.22	-2.85	-3.20	-14.16	-9.06
Shares Outstanding (Basic, Weighted)(shares)	262	240	222	212	179	29	29
Shares Outstanding (Diluted, Weighted)(shares)	262	266	222	212	179	29	29
EBITDA	-367	89	-205	-575	-530	-391	-252
Premiums Earned	11,470	8,971	5,686	3,871	1,831	455	469
Net Investment Income	203	186	155	28	2.40	8.01	11
Policyholder Benefits & Claims	10,019	7,333	4,642	3,281	1,624	309	408

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 4.1%
Net margin: 3.6%
Return on equity, FY2025: -44.5%

Financial strength

Current ratio: 1.08
Debt to equity: 0.21
Debt to assets: 3.8%
Cash to current liabilities: 46.9%

Valuation

P/E ratio: 23.2
Price to sales: 0.71
Price to book: 5.29
Dividend yield: –